Diagnosis, Differential Diagnosis, and Epidemiology of Primary Sclerosing Cholangitis

Digestive Diseases

Volumn 33, Issue , 2015, Pages 134-139

  Ponsioen, Cyriel Y ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Diagnosis; Epidemiology; Primary sclerosing cholangitis

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4;

ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILE DUCT CARCINOMA; CHOLANGIOGRAPHY; CHOLANGITIS; COLON CROHN DISEASE; COLORECTAL CARCINOMA; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC ULTRASONOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; INFLAMMATORY BOWEL DISEASE; LIVER BIOPSY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN EXPRESSION; ULCERATIVE COLITIS; CHOLANGITIS, SCLEROSING;

CHOLANGITIS, SCLEROSING; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 84977455647     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000440823     Document Type: Article

References (33)

1. Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, et al: Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 2013; 58: 2045-2055.
2. Delbet P: Retrecissement du choledoque cholecystoduodenostomie. Bull Mem Soc Chir Paris 1924; 50: 3.
3. Hoffman C: Verschluss der Gallenwege durch Verdickung der Wandungen. Arch Pathol Anat Physiol 1867; 49: 206-215.
4. Wiesner RH, LaRusso NF: Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79: 200-206.
5. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al: Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21: 870-877.
6. Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT: Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1981; 1: 632-640.
7. Craig DA, MacCarty RL, Wiesner RH, Grambsch PM, LaRusso NF: Primary sclerosing cholangitis: value of cholangiography in determining the prognosis. AJR Am J Roentgenol 1991; 157: 959-964.
8. Majoie CB, Reeders JW, Sanders JB, Huibregtse K, Jansen P: Primary sclerosing cholangitis: a modified classification of cholangiographic findings. AJR Am J Roentgenol 1991; 157: 495-497.
9. Ponsioen CY, Vrouenraets SM, Prawirodirdjo W, Rajaram R, Rauws EA, Mulder CJ, et al: Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 2002; 51: 562-566.
10. Ponsioen CY, Reitsma JB, Boberg KM, Aabakken L, Rauws EA, Schrumpf E: Validation of a cholangiographic prognostic model in primary sclerosing cholangitis. Endoscopy 2010; 42: 742-747.
11. Hazel van de SJ, Wolfhagen F, van Buuren HR, Meeberg van de P, Leeuwen van DJ: Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis. Dutch PSC Study Group. Endoscopy 2000; 32: 779-782.
12. Alkhatib AA, Hilden K, Adler DG: Comorbidities, sphincterotomy, and balloon dilation predict post-ERCP adverse events in PSC patients: operator experience is protective. Dig Dis Sci 2011; 56: 3685-3688.
13. Navaneethan U, Jegadeesan R, Nayak S, Lourdusamy V, Sanaka MR, Vargo JJ, et al: ERCPrelated adverse events in patients with primary sclerosing cholangitis. Gastrointest Endosc 2015; 81: 410-419.
14. Dave M, Elmunzer BJ, Dwamena BA, Higgins PD: Primary sclerosing cholangitis: metaanalysis of diagnostic performance of MR cholangiopancreatography. Radiology 2010; 256: 387-396.
15. Nolz R, Asenbaum U, Schoder M, Wibmer A, Einspieler H, Prusa AM, et al: Diagnostic workup of primary sclerosing cholangitis: the benefit of adding gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography to conventional T2-weighted magnetic resonance cholangiography. Clin Radiol 2014; 69: 499-508.
16. Ruiz A, Lemoinne S, Carrat F, Corpechot C, Chazouilleres O, Arrive L: Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology 2014; 59: 242-250.
17. Nilsson H, Blomqvist L, Douglas L, Nordell A, Jacobsson H, Hagen K, et al: Dynamic gadoxetate-enhanced MRI for the assessment of total and segmental liver function and volume in primary sclerosing cholangitis. J Magn Reson Imaging 2014; 39: 879-886.
18. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al: Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010; 51: 660-678.
19. European Association for the Study of the Liver: EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237-267.
20. Erkelens GW, Vleggaar FP, Lesterhuis W, van Buuren HR, van der Werf SD: Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet 1999; 354: 43-44.
21. Boonstra K, Culver EL, de Buy Wenniger LM, van Heerde MJ, van Erpecum KJ, Poen AC, et al: Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology 2014; 59: 1954-1963.
22. Tokala A, Khalili K, Menezes R, Hirschfield G, Jhaveri KS: Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis. AJR Am J Roentgenol 2014; 202: 536-543.
23. Trikudanathan G, Navaneethan U, Njei B, Vargo J, Parsi M: Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc 2014; 79: 783-789.
24. Navaneethan U, Njei B, Venkatesh PG, Vargo JJ, Parsi MA: Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc 2014; 79: 943-950.e3.
25. Navaneethan U, Njei B, Venkatesh PG, Lourdusamy V, Sanaka MR: Endoscopic ultrasound in the diagnosis of cholangiocarcinoma as the etiology of biliary strictures: a systematic review and meta-analysis. Gastroenterol Rep (Oxf) 2015; 3: 209-215.
26. Weilert F, Bhat YM, Binmoeller KF, Kane S, Jaffee IM, Shaw RE, et al: EUS-FNA is superior to ERCP-based tissue sampling in suspected malignant biliary obstruction: results of a prospective, single-blind, comparative study. Gastrointest Endosc 2014; 80: 97-104.
27. Abdalian R, Heathcote EJ: Sclerosing cholangitis: a focus on secondary causes. Hepatology 2006; 44: 1063-1074.
28. Boonstra K, Beuers U, Ponsioen CY: Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 2012; 56: 1181-1188.
29. Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV: Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol 2002; 97: 2402-2407.
30. Bambha K, Kim WR, Talwalkar JA, Torgerson H, Benson JT, Therneau TM, et al: Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125: 1364-1369.
31. Boonstra K, van Erpecum, KJ, van Nieuwkerk KMJ, Drenth JPH, Poen AC, Witteman BJM, Tuynman HARE, Beuers U, Ponsioen CY: Primary sclerosing cholangitis is associated with a distinct type of inflammatory bowel disease. IBD 2012; 18: 2270-2276.
32. Tanaka A, Takikawa H: Geoepidemiology of primary sclerosing cholangitis: a critical review. J Autoimmu 2013; 46: 35-40.
33. Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan JY: Clinical profile of primary sclerosing cholangitis in Singapore. J Gastroenterol Hepatol 2002; 17: 908-913.